Codexis, Inc. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $140 M for Codexis, Inc., 3.7 times as much (market caps of Oct 26, 2026 for Codexis, Inc. and Oct 6, 2026 for Regenxbio Inc.).
- Regenxbio Inc. had more revenue: $170 M against $70 M for Codexis, Inc., both in the year to December 2025.
- Both made a net loss: $44 M for Codexis, Inc. and $194 M for Regenxbio Inc.
- Codexis, Inc. keeps more of each dollar of sales: a net margin of -62.5% against -113.8% for Regenxbio Inc.
- Regenxbio Inc. employs more people: 372 against 261 at Codexis, Inc. Each employee brings in about $269,693 of revenue at Codexis, Inc. and $458,172 at Regenxbio Inc.
- Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +18.6% for Codexis, Inc.
- Both are in the distress zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Codexis, Inc. CDXS · #17,521 in the world | Regenxbio Inc. RGNX · #12,428 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2002 | — |
| Size | ||
| Market cap | $140 M | $513 M |
| Revenue | $70 M | $170 M |
| Net income | $-44 M▲ best | $-194 M |
| Employees | 261 | 372 |
| Valuation | ||
| Price to sales | 1.6× | 3.3× |
| Price to book | 2.8× | 5.0× |
| Free cash flow yield | -17.0%▲ best | -24.6% |
| Profitability | ||
| Gross margin | 86.7% | — |
| Operating margin | -59.3%▲ best | -94.6% |
| Net margin | -62.5%▲ best | -113.8% |
| Return on equity | -74.9%▲ best | -107.0% |
| Growth | ||
| Revenue growth | 18.6% | 104.5%▲ best |
| Revenue growth, 3 years a year | -20.2% | 14.8%▲ best |
| Financial strength | ||
| Debt to equity | 0.8× | — |
| Cash | ||
| Free cash flow margin | -33.9%▲ best | -74.1% |
| Strength scores | ||
| Piotroski F-score | 4 of 9 | — |
| Altman Z-score zone | distress | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Codexis, Inc. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $140 M for Codexis, Inc., 3.7 times as much (market caps of Oct 26, 2026 for Codexis, Inc. and Oct 6, 2026 for Regenxbio Inc.).
Which makes more money, Codexis, Inc. or Regenxbio Inc.?
Regenxbio Inc. had more revenue: $170 M against $70 M for Codexis, Inc., both in the year to December 2025. Both made a net loss: $44 M for Codexis, Inc. and $194 M for Regenxbio Inc.
Which is more profitable, Codexis, Inc. or Regenxbio Inc.?
Codexis, Inc. keeps more of each dollar of sales: a net margin of -62.5% against -113.8% for Regenxbio Inc.
Which has more employees, Codexis, Inc. or Regenxbio Inc.?
Regenxbio Inc. employs more people: 372 against 261 at Codexis, Inc. Each employee brings in about $269,693 of revenue at Codexis, Inc. and $458,172 at Regenxbio Inc.
Which is growing faster, Codexis, Inc. or Regenxbio Inc.?
Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +18.6% for Codexis, Inc.
Which is financially stronger, Codexis, Inc. or Regenxbio Inc.?
Both are in the distress zone of the Altman Z-score.
More about Codexis, Inc.
More about Regenxbio Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.